Characteristics and Outcomes After Transcatheter Aortic Valve Implantation in Immunocompromised Patients.

Ghannam, Alexander; Gharacholou, S Michael; Ball, Colleen T; Pollak, Peter M; Parikh, Pragnesh P; Landolfo, Carolyn; Ali, Mays T; Landolfo, Kevin

Ghannam, Alexander; Gharacholou, S Michael; Ball, Colleen T; Pollak, Peter M; Parikh, Pragnesh P; Landolfo, Carolyn; Ali, Mays T; Landolfo, Kevin.

Affiliation

Ghannam A; Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, South Carolina.
Gharacholou SM; Department of Cardiovascular Disease, Mayo Clinic, Jacksonville, FL. Electronic address: gharacholou.shahyar@mayo.edu.
Ball CT; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL.
Pollak PM; Department of Cardiovascular Disease, Mayo Clinic, Jacksonville, FL.
Parikh PP; Department of Cardiovascular Disease, Mayo Clinic, Jacksonville, FL.
Landolfo C; Department of Cardiovascular Disease, Mayo Clinic, Jacksonville, FL.
Ali MT; Department of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.
Landolfo K; Department of Cardiac Surgery, Mayo Clinic, Jacksonville, Florida.

Am J Cardiol ; 173: 100-105, 2022 06 15.

Article de En | MEDLINE | ID: mdl-35367046

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sténose aortique / Implantation de valve prothétique cardiaque / Remplacement valvulaire aortique par cathéter / Tumeurs Type d'étude: Etiology_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Am J Cardiol Année: 2022 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google